Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic
  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

DNA Diagnostics-Testing Market Is Expected to Witness Higher Demands Till 2022: Grand View Research, Inc.

DNA Diagnostics-Testing Market Is Expected to Witness Higher Demands Till 2022: Grand View Research, Inc.
Grand View Research, Inc. - Market Research And Consulting.
According to report published by Grand View Research, rise in developments in the field of genome sequencing and personalized DNA level diagnostic applications, a considerable growth in the number of patented research initiatives by the government and government funded projects are factors expected to drive demand during the forecast period.

According to a report,“DNA Testing/Diagnostics Market Analysis By Technology (Microarray Based, PCR Based, In-situ Hybridization, NGS DNA Diagnosis), By Application (Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics (HBV, HCV, HIV, TB, CT/NG, HPV, & MRSA), Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, Pharmacogenomics Diagnostic Testing, & Drug Metabolism/P450 Effects), And Segment Forecasts To 2022”, published by Grand View Research, Inc., Global DNA testing market is anticipated to reach USD 10.04 billion by 2022. Rise in developments in the field of genome sequencing and personalized DNA level diagnostic applications, a considerable growth in the number of patented research initiatives by the government and government funded projects are factors expected to drive demand during the forecast period.

Key Takeaways from the report:

  • PCR based diagnosis accounted for the largest share of the market revenue in 2014 as a result of higher preference rate coupled with higher availability of products and reagent kits of this segment.

  • Next generation sequencing application for DNA testing is estimated to witness significant progress with a double digit CAGR of over 16% amongst the other technology segments due to presence of significant advantages offered by this technique of DNA identification and testing.

  • Infectious disease diagnostics accounted for the largest market share in 2014 due to higher incidence rate of various infectious disorders which subsequently raises the demand for in-vitro nucleic acid based diagnostic tests for diagnosis and monitoring of disease progression.

  • There are diverse applications of DNA testing market out of which oncology diagnostics and histopathology is estimated to register lucrative growth over the forecast period. Factors attributing for considerable growth potential in this segment include identification of cancer causing genes & associated research, and facilitation in mutation detection

  • North America dominated the market in 2014, with revenue estimated at over USD 2,600 million. Presence of sophisticated healthcare infrastructure, rising incidence of genetic abnormalities, favorable government initiatives with respect to genetic diagnosis and its application in in-vitro fertilization are major factors driving growth of this region.

  • Asia Pacific is anticipated to witness lucrative growth as a result of developments in health care infrastructure in this region coupled with presence of significant number of target population that is suffering with chronic as well as acute disorders. Government initiatives taken up herein are also attributive to influence sector growth to a great extent.

  • Key participants of DNA testing industry include Abbott Laboratories, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Applied Biosystems Group, Cepheid Inc., Transgenomic Inc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Alere Inc, Affymetrix Inc., Hologic, Dako, and 454 Life Sciences.

U.S. DNA testing market, by application, 2012 - 2022 (USD Million)

U.S. DNA testing market, by application, 2012 - 2022 (USD Million)

Browse More Reports in Biotechnology:

  • Bioinformatics Market: Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the bioinformatics market growth over the next five years. 
  • Carcinoembryonic Antigen (CEA) Market: Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period.

Introduction of novel technologies for genome profiling are expected to boost progress of this industry over the forecast period. Furthermore, increasing incidences of chronic oncology and infectious diseases that depend on DNA prototyping for treatment and diagnosis using personalized medicine are anticipated to significantly raise demand for DNA diagnostics/testing based research thereby propelling industrial growth in the coming years. Increasing demand for prenatal testing and in-vitro fertilization that subsequently leads to rise in demand for DNA diagnostics/testing is also attributive towards expected progress in this market.

Grand View Research has segmented DNA testing market on the basis of technology, application, and region:

 Global DNA Diagnostics/Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)

  • Microarrays based diagnostics

  • PCR based diagnostics

  • In-situ hybridization diagnostics

  • NGS DNA diagnosis

Global DNA Diagnostics/Testing Application Outlook (Revenue, USD Million, 2012 - 2022)

  • Prenatal DNA Carrier Screening

  • Preimplantation Diagnosis

  • Newborn Genetic Screening

  • Infectious Disease Diagnostics

    • HBV Diagnostic

    • HCV Diagnostic

    • HIV Diagnostic

    • TB Diagnostic

    • CT/NG Diagnostic

    • HPV Diagnostic

    • MRSA Diagnostic

    • Others

  • Oncology Diagnostics & Histopathology

  • Identity Diagnostics & Forensics

  • Pharmacogenomics Diagnostic Testing

  • Drug Metabolism & P450 effects

  • Others

DNA Diagnostics/Testing Regional Outlook (Revenue, USD Million, 2012 - 2022)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

Explore dna diagnostics-testing market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/dna-testing-market



Source: www.abnewswire.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.